United Capital Financial Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-677
Closed -$111K 1062
2024
Q2
$111K Buy
+677
New +$96.4K ﹤0.01% 1004
2023
Q2
Sell
-560
Closed -$332K 891
2023
Q1
$332K Sell
560
-1,104
-66% -$618K ﹤0.01% 797
2022
Q4
$671K Buy
1,664
+303
+22% +$142K ﹤0.01% 704
2022
Q3
$797K Sell
1,361
-4
-0.3% -$2.4K ﹤0.01% 661
2022
Q2
$745K Buy
+1,365
New +$690K ﹤0.01% 693

Other funds holding AGL

United Capital Financial Advisors's AGL Position: Q3 2024 in Review

United Capital Financial Advisors sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 677 shares — an estimated $111K sold.

United Capital Financial Advisors first reported a position in AGL in Q2 2022 and held it in 5 quarters. The position peaked at $797K in Q3 2022. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • United Capital Financial Advisors reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • United Capital Financial Advisors sold 677 Agilon Health shares in Q3 2024, an estimated $111K.
  • United Capital Financial Advisors first reported a position in Agilon Health in Q2 2022 and held it in 5 quarters.
  • United Capital Financial Advisors's Agilon Health position peaked at $797K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on United Capital Financial Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.